Sanofi, Shire interested in ViroPharma: Bloomberg

|About: Shire PLC (SHPG)|By:, SA News Editor

Details emerge on a possible ViroPharma (VPHM +27.4%) sale after Bloomberg initially reported the firm had hired Goldman to help it evaluate its options.

Citing sources, Bloomberg identifies Sanofi (SNY +0.1%) and Shire (SHPG +1.1%) as the interested parties.

Meanwhile, the Street is busy trying to nail the valuation.

Mark Deutsche down for $46-52/share.

More on the prospective deal here